Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nanobiotix S.A. ADR
(NQ:
NBTX
)
4.935
+0.185 (+3.89%)
Streaming Delayed Price
Updated: 2:34 PM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nanobiotix S.A. ADR
< Previous
1
2
3
4
5
6
7
8
9
Next >
Nanobiotix's Radiotherapy Combo Therapy Shows Boosted Anti-Tumor Activity In Preclinical Studies
April 12, 2022
Nanobiotix SA (NASDAQ: NBTX)
Via
Benzinga
NANOBOTIX: New Preclinical Immunotherapy Data Show Boosted Anti-Tumor Immune Activation via Triple Blockade of PD-1, LAG-3, and TIGIT When Combined With Radiotherapy-Activated NBTXR3
April 11, 2022
From
NANOBOTIX
Via
Business Wire
NANOBIOTIX Announces Filing of the 2021 Universal Registration Document and the 2021 Annual Report on Form 20-F
April 08, 2022
From
NANOBIOTIX
Via
Business Wire
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
April 07, 2022
From
Nanobiotix
Via
Business Wire
NANOBIOTIX Provides Business Update and Reports Full Year 2021 Financial Results
March 30, 2022
From
NANOBIOTIX
Via
Business Wire
Earnings Scheduled For March 30, 2022
March 30, 2022
Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021.
Via
Benzinga
NANOBIOTIX to Announce Full Year 2021 Financial Results on March 30, 2022
March 16, 2022
From
NANOBIOTIX
Via
Business Wire
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
February 10, 2022
From
NANOBIOTIX
Via
Business Wire
Nanobiotix Announces Publication of New Clinical Case Study Highlighting First Patient Experience of NBTXR3 Treatment for Pancreatic Cancer
February 09, 2022
From
Nanobiotix
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 02, 2022
Gainers Epizyme (NASDAQ:EPZM) stock increased by 14.2% to $1.41 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 9.6...
Via
Benzinga
NANOBIOTIX Announces Publication of New Preclinical Immunotherapy Data Showcasing the Combination Potential of NBTXR3 With anti-PD-1 and anti-CTLA-4
January 26, 2022
From
NANOBIOTIX
Via
Business Wire
Is Oncolytics Biotech's GOBLET Study Making Headway in the Fight Against Pancreatic and Colorectal Tumors?
January 25, 2022
Photo by Lucas Vasques on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice....
Via
Benzinga
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
January 11, 2022
From
Nanobiotix
Via
Business Wire
NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets
January 10, 2022
From
NANOBIOTIX
Via
Business Wire
58 Biggest Movers From Yesterday
January 07, 2022
Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 06, 2022
Gainers Eargo (NASDAQ:EAR) stock increased by 50.0% to $6.84 during Thursday's regular session. The current volume of 90.4 million shares is 5474.6% of Eargo's...
Via
Benzinga
NANOBIOTIX Announces First Patient Enrolled in NANORAY-312 Global Phase III Registrational Study of NBTXR3 in Head and Neck Cancer
January 05, 2022
From
NANOBIOTIX
Via
Business Wire
Nanobiotix Announces Participation at Three Virtual Investor Conferences in January 2022
January 04, 2022
From
Nanobiotix
Via
Business Wire
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
December 08, 2021
From
Nanobiotix
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 08, 2021
Gainers Lexaria Bioscience (NASDAQ:LEXX) shares increased by 30.28% to $6.41 during Wednesday's pre-market session. The company's market cap stands at $36.7...
Via
Benzinga
NANOBIOTIX to Present at the 4th Annual Evercore ISI HealthCONx Conference
November 17, 2021
From
NANOBIOTIX
Via
Business Wire
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
NANOBIOTIX Announces New Preclinical Data Highlighting NBTXR3 Immune Priming and Checkpoint Inhibitor Combination
November 09, 2021
From
NANOBIOTIX
Via
Business Wire
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
November 08, 2021
From
Nanobiotix
Via
Business Wire
NANOBIOTIX to Participate in a Fireside Chat at the Jefferies London Healthcare Conference
November 03, 2021
From
Nanobiotix
Via
Business Wire
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
October 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M...
Via
Benzinga
NANOBIOTIX Announces 18.1 Month Median Overall Survival for 41 Evaluable Elderly and Frail Patients With HNSCC in Phase I Expansion Evaluating Nbtxr3 as a Single Agent Activated by Radiotherapy
October 24, 2021
From
NANOBIOTIX
Via
Business Wire
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...
Via
Benzinga
Exposures
Product Safety
NANOBIOTIX Provides Third Quarter Operational and Financial Update
October 20, 2021
From
NANOBIOTIX
Via
Business Wire
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
October 08, 2021
From
Nanobiotix
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.